首页> 外国专利> use of a human interleukin-2 mutein (hil-2 mutein) or a fragment thereof, pharmaceutical composition for the treatment and / or prophylaxis of an autoimmune disease, use of human interleukin-2 mutein (hil-2 mutein) 2) or a section thereof, for the formation of regulatory t cells (treg) in an organism, method for treatment and / or prophylaxis of an autoimmune disease in an organism, method for formation of regulatory t cells (treg) in an organism organism, method for formation of regulatory t cells (treg) in vitro.

use of a human interleukin-2 mutein (hil-2 mutein) or a fragment thereof, pharmaceutical composition for the treatment and / or prophylaxis of an autoimmune disease, use of human interleukin-2 mutein (hil-2 mutein) 2) or a section thereof, for the formation of regulatory t cells (treg) in an organism, method for treatment and / or prophylaxis of an autoimmune disease in an organism, method for formation of regulatory t cells (treg) in an organism organism, method for formation of regulatory t cells (treg) in vitro.

机译:人白介素2突变蛋白(hil-2突变蛋白)或其片段的用途,用于治疗和/或预防自身免疫性疾病的药物组合物,人白介素2突变蛋白(hil-2突变蛋白)2的用途或其部分,用于在生物中形成调节性t细胞(treg),在生物中治疗和/或预防自身免疫性疾病的方法,在生物中形成调节性t细胞(treg)的方法,形成方法体外调节性t细胞(treg)的表达。

摘要

The present invention relates to an agent for the treatment and/or prophylaxis of an autoimmune disease, an agent for the formation of regulatory T cells (TReg) in an organism and various methods in which the agents according to the invention are used.
机译:本发明涉及用于治疗和/或预防自身免疫疾病的试剂,用于在生物体中形成调节性T细胞(TReg)的试剂,以及使用根据本发明的试剂的各种方法。

著录项

  • 公开/公告号BRPI0912411A2

    专利类型

  • 公开/公告日2016-09-13

    原文格式PDF

  • 申请/专利权人 AICURIS GMBH & CO. KG.;

    申请/专利号BR2009PI12411

  • 发明设计人 DANIELA PAULSEN;DOROTHY BRAY;NINA BRUNNER;

    申请日2009-04-28

  • 分类号A61K38/20;A61P37;A61P37/06;

  • 国家 BR

  • 入库时间 2022-08-21 14:26:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号